Partnerships to provide care and medicine for chronic diseases: a model for emerging markets.
The challenge of expanding access to treatment and medicine for chronic diseases in emerging markets is both a public health imperative and a commercial opportunity. Cross-sector partnerships-involving a pharmaceutical manufacturer; a local health care provider; and other private, public, and nonprofit entities-could address this challenge. Such partnerships would provide integrated, comprehensive care and medicines for a specific chronic disease, with medicines directly supplied to the partnership at preferential prices by the manufacturer. The model discussed here requires additional specification, using real numbers and specific contexts, to assess its feasibility. Still, we believe that this model has the potential for public health and private business to cooperate in addressing the rising problem of chronic diseases in emerging markets.
Harvard School of Public Health, Boston, Massachusetts, USA. michaelgoroff@mac.com
Michael
M
Goroff
Michael R
MR
Reich
D002908:Chronic Disease / Q000188:drug therapy*; D003695:Delivery of Health Care / Q000458:organization & administration*; D003906:Developing Countries; D006297:Health Services Accessibility; D006801:Humans; D017146:Models, Organizational; D055818:Public-Private Sector Partnerships